A 30-year-old G4P0A2E1 female, whose LMP: 2009/4/6 and EDC: 2010/1/14, was admitted for complaining painful uterine contraction. MgSO4 is the first choice for her instead of Yutopar because her blood sugar was over the standard in OPD.
(Yutopar can be prescribed if labor begins between 20 and 36 weeks gestation and if the fetus weighs between 500 and 2,499 grams. The initial dose of Yutopar is usually given intravenously. Once the best dose for the patient is found, she may receive the medication by oral or intramuscular route. The amount and frequency of subsequent dosages depend on the woman's response to the initial therapy.
Yutopar should not be used in women who have cardiovascular disease, pregnancy-induced high blood pressure, intrauterine infection, vaginal bleeding, or uncontrolled diabetes. Nor should it be used if the woman is in active labor or has a history of repeated miscarriages due to an incompetent cervix, or if the fetal membranes have ruptured.
Side effects include: heart palpitations, excessively rapid heartbeat, tremors, anxiety, headaches, dizziness, evaluation of blood glucose, sodium retention, pulmonary edema, nausea, vomiting, flush and fever. )
(When a woman in pre-term labor also has diabetes or heart disease, she may be placed on magnesium sulfate to reduce uterine activity. Magnesium sulfate is approved for magnesium deficiency states but not specifically for use in pre-term labor. However, because there is extensive literature and clinical data on this use, some physicians prescribe it. The most uncomfortable side effect of magnesium sulfate is a feeling of warmth and flushing when the drug is first administered. Women must also be carefully monitored for respiratory or cardiac complications during the therapy. )
延伸閱讀：High Risk Pregnancy
留言列表
